Skip to main content
Equibles

JACOBS LEVY EQUITY MANAGEMENT, INC

Position in EDIT — Editas Medicine, Inc.

CIK 884414 FLORHAM PARK, NJ
Back to EDIT Full portfolio

Position in EDIT

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$445,030
-$993,273 QoQ
Shares Held
137,355
-76.4% QoQ
Ownership
0.089%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#60
of 216 holders
Holding Since
Mar 2020
19 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in EDIT Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

JACOBS LEVY EQUITY MANAGEMENT, INC holds $740,535,030 across 80 Biotechnology names. EDIT ranks #66 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 REGN
Regeneron Pharmaceuticals, Inc.
 256,503 $159,939,880
2 RARE
Ultragenyx Pharmaceutical Inc.
 2,939,719 $98,157,217
3 INCY
Incyte Corp
 731,774 $82,953,900
4 CORT
Corcept Therapeutics Inc
 695,532 $60,476,507
5 HALO
Halozyme Therapeutics, Inc.
 322,377 $25,232,447
6 EXEL
Exelixis, Inc.
 415,650 $22,615,516
7 AUPH
Aurinia Pharmaceuticals Inc.
 1,231,516 $20,898,826
8 ALNY
Alnylam Pharmaceuticals, Inc.
 60,986 $18,358,615

All Filings in EDIT

Export CSV
19 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $445,030 137,355
2026-03-31 $1,438,303 582,309
2025-12-31 $1,695,637 827,140
2025-09-30 $2,776,079 800,023
2025-06-30 $204,252 92,842
2024-12-31 $899,679 708,409
2024-09-30 $1,806,733 529,834
2024-06-30 $1,060,939 227,182
2024-03-31 $884,018 119,140
2023-12-31 $2,885,307 284,828
2023-09-30 $648,148 83,096
2023-06-30 $151,053 18,354
2022-12-31 $133,963 15,103
2022-09-30 $1,311,369 107,138
2022-03-31 $1,439,034 75,659
2020-12-31 $4,861,777 69,345
2020-09-30 $2,525,961 90,020
2020-06-30 $3,327,572 112,494
2020-03-31 $1,337,949 67,471